- Home
- TR vs CPRX Comparison
TR vs CPRX Comparison
Compare TR & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TR
- CPRX
- Stock Information
- Founded
- TR 1896
- CPRX 2002
- Country
- TR United States
- CPRX United States
- Employees
- TR N/A
- CPRX N/A
- Industry
- TR Specialty Foods
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- TR Consumer Staples
- CPRX Health Care
- Exchange
- TR Nasdaq
- CPRX Nasdaq
- Market Cap
- TR 2.9B
- CPRX 2.6B
- IPO Year
- TR N/A
- CPRX 2006
- Fundamental
- Price
- TR $40.84
- CPRX $20.29
- Analyst Decision
- TR
- CPRX Strong Buy
- Analyst Count
- TR 0
- CPRX 5
- Target Price
- TR N/A
- CPRX $33.20
- AVG Volume (30 Days)
- TR 146.2K
- CPRX 1.4M
- Earning Date
- TR 10-23-2025
- CPRX 11-05-2025
- Dividend Yield
- TR 0.88%
- CPRX N/A
- EPS Growth
- TR N/A
- CPRX 183.96
- EPS
- TR 1.24
- CPRX 1.65
- Revenue
- TR $722,849,000.00
- CPRX $558,499,000.00
- Revenue This Year
- TR N/A
- CPRX $16.51
- Revenue Next Year
- TR N/A
- CPRX $9.58
- P/E Ratio
- TR $32.51
- CPRX $12.29
- Revenue Growth
- TR N/A
- CPRX 28.55
- 52 Week Low
- TR $28.18
- CPRX $19.00
- 52 Week High
- TR $41.27
- CPRX $26.58
- Technical
- Relative Strength Index (RSI)
- TR 64.65
- CPRX 47.06
- Support Level
- TR $39.98
- CPRX $19.17
- Resistance Level
- TR $41.27
- CPRX $21.19
- Average True Range (ATR)
- TR 0.77
- CPRX 0.72
- MACD
- TR -0.01
- CPRX 0.02
- Stochastic Oscillator
- TR 84.75
- CPRX 42.26
About TR Tootsie Roll Industries Inc.
Tootsie Roll Industries Inc manufactures and sells confectionery products. Notable varieties include Tootsie Roll and Tootsie Pops, Charms, Blow-Pops, Dots, Junior Mints, Sugar Daddy and Sugar Babies, Andes, Dubble Bubble, Razzles among others. The company sells its products to wholesale distributors and directly to retail stores. Geographically, it generates a majority of its revenue from the United States and rest from Canada, Mexico and other regions.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).